On 14 February 2023, the European Parliament voted to ban the sale of new petrol and diesel CO2-emitting cars as of 2035, making headway in the EU’s “Fit for 55” package and the transition to climate neutrality by 2050.
This paper starts from an empirical observation that levels of hunger or food insecurity in middle-income and high-income countries are often higher than might be expected, and in some cases are rising rather than falling in recent years.
This study presents current (2020) waste and residue feedstock availability in the European Union and the United Kingdom and provides projections for 2030 and 2050. The study considers the availability of agricultural residues, forestry residues, and biogenic waste.
The report highlights the collaborative action already happening between cities, states, regions, business, and national government, using data reported by over 1000 cities, states and regions through the CDP-ICLEI Unified Reporting System.
Reducing global carbon dioxide (CO2) emissions to net zero by 2050 is necessary to limit the long‐term increase in average global temperatures to 1.5 °C. Today, coal-fired power generation is the largest single source of CO2 emissions. Therefore, tackling emissions from this sector is critical to achieving our goal.
The report, Switching Gears: Achieving Climate Smart Fisheries, shows that we must address the environmental impacts of fisheries, or risk derailing the UK’s climate and nature recovery goals. The UK already has world-leading legislation in place to modernise the UK fishing sector in the form of the UK Fisheries Act, 2020.
This report uses four case studies from across the globe to draw lessons on how cities and regions can equitably manage the decline of major industrial and mining activities and minimize disruption to local economies.
Microbiological characterisation of co-infections and secondary infections in patients with COVID-19 is lacking, and antimicrobial use is high. The researchers aimed to describe microbiologically confirmed co-infections and secondary infections, and antimicrobial use, in patients admitted to hospital with COVID-19